Le Lézard3 日
Soligenix to Present at November 21st Virtual Investor Summit Microcap Event
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
Spectral AI Announces 2024 Third Quarter Financial Results
Revenue Rose to $8.2 MillionCompany Reaffirms Timeline for Regulatory Submission to U.S. FDAQ3 2024 OverviewResearch & Development Revenue ...
Soligenix, Inc.: Soligenix to Present at November 21st Virtual Investor Summit Microcap Event
PRINCETON, NJ / ACCESSWIRE / November 15, 2024 / Soligenix, Inc. (Nasdaq:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...